Invest Now
Samco Star Rating Ads

Price Performance

  • Day's Low
  • ₹1,543.45
  • Day's High
  • ₹1,576.25
₹ 1,571.25
  • 52-w low
  • ₹922.45
  • 52-w high
  • ₹1,627
1,571.25
  • Day's open
    ₹1,548.25
  • Previous close
    ₹1,548.20
  • VWAP
    ₹1,561.10
  • Lower price band
    ₹1,414.15
  • Upper price band
    ₹1,728.35

Today's Market Action

The last traded share price of Sun Pharmaceuticals Industries Ltd was 1,571.25 up by 1.37% on the NSE. Its last traded stock price on BSE was 1,571.45 up by 1.54%. The total volume of shares on NSE and BSE combined was 2,281,873 shares. Its total combined turnover was Rs 356.22 crores.

Medium and Long Term Market Action

Sun Pharmaceuticals Industries Ltd hit a 52-week high of 1,627 on 11-03-2024 and a 52-week low of 922.45 on 18-05-2023. The stock price of Sun Pharmaceuticals Industries Ltd is up by 5% over the last one month. It is up by 64.17% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 376996

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Sun Pharmaceuticals Industries Ltd?

What is the Market Cap of Sun Pharmaceuticals Industries Ltd?

What is PE Ratio of Sun Pharmaceuticals Industries Ltd?

What is PB Ratio of Sun Pharmaceuticals Industries Ltd?

What is the CAGR of Sun Pharmaceuticals Industries Ltd?

How to Buy Sun Pharmaceuticals Industries Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Momentum Strength
    The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
  • High Pricing Power
    The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
  • Asset Light Business
    The company operates a great asset light business with a high Asset turnover ratio of Infinity. A high asset turnover ratio is a great driver of RoE and can improve shareholder returns. A relatively higher asset turnover ratio also will result in lower dilution as the business grows its revenues as earnings.
  • Zero Debt
    The company has almost nil to negligible debt to equity ratio of 0.00. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.
  • Strong Working Capital Cycle
    The company has a great working capital cycle of 0 days which results in lower investments in working capital and higher asset turnover. This reduces capital requirement of the business and drives RoE and cash flow generation positively. This is extremely positive for long term shareholders of the business.
  • High Shareholder Pedigree
    The company has a solid long term shareholder base which reduces the degree of speculation and volatility in the stock. This works well for long term equity shareholders.

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Negative Margin of Safety
    The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(19/03/2024)
Stock Valuation
Yellow line
89
90.48%
90.48% People are bullish about Sun Pharmaceuticals Industries Ltd
9.52%
9.52 % People are bearish about Sun Pharmaceuticals Industries Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Sun Pharmaceuticals Industries Ltd

1,571.25 +21.15 (1.37%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %